INSIGHTS ON QUALITY ASSURANCE

QUALITY ASSURANCE SOLUTIONS

  • Elevate production safety with high-speed detection that identifies small contaminants while reducing waste. Intuitive controls and durable design ensure long-term efficiency and reliability.

  • Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.

  • Explore automated electrophoresis solutions for vaccine development to ensure precise sample quality control and how these innovations streamline workflows and enhance reliability in vaccine research.

  • Proactively manage risks of pharmaceuticals, medical devices and other products with TrackWise Digital. The built-in templates comply with ISO 14971 and ICH Q9 allowing manufacturers to manage risks throughout the entire product lifecycle directly within TrackWise Digital.

  • V11 Label Inspection System

    Adaptable, integrable, and cost-effective. This flexible label inspection solution reliably inspects oriented products from the sides or top for label data and quality defects. It can be easily integrated into existing production lines utilizing smart cameras, lighting, and software.

    100% Automated Label Inspection

    Affordable vision system ideally suited to replace manual spot checks with 100% automated label inspection control for high-speed production lines.

    Compliance Support

    The V11 provides documented label inspection in line with industry guidelines such as IFS and BRCGS to support consumer safety.

    Prevent Recalls and Reduce Waste

    The V11 verifies labels to detect and reliably sort non-conforming products. False or missing declarations often lead to costly recalls.